Table 2

Characteristics of patients positive for COVID-19

Without MetS n=46MetS n=33P value
Male, N (%)23 (50.0)14 (42.4)0.506
Age, years, median (IQR)48.5 (34–60.3)56.0 (45.3–61.8)0.107
BMI in kg/m2, median (IQR)26.5 (23.8–31.4)30.4 (27.2–35.8)0.004
MetS, N (%)
 Use of antihypertensives, N (%)*4 (8.7)17 (51.5)
 High triglycerides, N (%)*2 (4.3)24 (72.7)
 Low HDL-C, N (%)*36 (87.3)33 (100)
 Hyperglycaemia, N (%)*2 (4.3)19 (57.6)
 Abdominal adiposity, N (%)*24 (52.2)29 (87.9)
Waist–hip ratio, median (IQR)0.93 (0.84–0.98)0.95 (0.90–1.02)0.034
History of pulmonary disease, N (%)10 (21.7)6 (18.2)0.698
History of cardiovascular disease, N (%)5 (10.9)11 (33.3)0.014
Use of antibiotics, N (%)19 (41.3)10 (30.3)0.274
Deceased (30-day follow-up), N (%)0 (0)0 (0)
Discharged from ER without hospitalisation, N (%)5 (11)0 (0)0.047
Hospitalisation, N (%)41 (89)33 (100)
Respiratory support†
 Intubation, N (%)7 (15)6 (18)0.989
 High-flow nasal cannula, N (%)4 (9)3 (9)
 Supplemental oxygen 1–6 L/min, N (%)24 (52)21 (64)
 60.111
 51 (2)2 (6)
 403 (9)
 34 (9)1 (3)
 29 (20)11 (33)
 110 (22)3 (9)
Hospitalised, without oxygen supply, N (%)6 (13)4 (12)
Unfavourable course of disease, N (%)16 (35)15 (45)0.338
Readmission ER related to COVID-19, N (%)7 (15)4 (12)0.658
  • Sufficient data to diagnose or exclude MetS were missing in seven patients. Median (IQR Q1–Q3) used in variables with non-normal distribution. Statistically significant p-values are bold.

  • *MetS criterion. Cut-off values: high triglycerides (>1.7 mmol/L), low HDL-C (<1 mmol/L in male, <1.3 mmol/L in female), hyperglycaemia ≥7.8 mmol/L and/or drug treatment for elevated blood glucose, abdominal adiposity (male ≥102 cm, female ≥88 cm).

  • †Respiratory support was defined as maximum supplemental oxygen at any given moment during hospitalisation.

  • BMI, body mass index; ER, emergency room; HDL-C, high-density lipoprotein cholesterol; MetS, metabolic syndrome; N, numbers.